Fig. 3
From: Monitoring drug nanocarriers in human blood by near-infrared fluorescence correlation spectroscopy

NIR-FCS measurement of IRDye®CW800-DBCO in flowing blood. a Autocorrelation curve fitted with Eq. (2) comprising contributions from fluorescent dyes and blood cells. b Contribution from the blood cells was subtracted (Eq. (6)) from the autocorrelation curve of IRDye®CW800-DBCO in blood (red). For comparison, the autocorrelation curve of IRDye®CW800-DBCO in water (black) is also shown